The DOI matches its Crossref record; 15 of the 15 references it cites were found in a registry or an index.
Characterization of Envelope and Core Structural Gene Products of HTLV-III with Sera from AIDS Patients
Abstract
The envelope ( env ) and structural ( gag ) gene products of human T-cell leukemia (lymphotropic) virus type III were identified by immunoaffinity chromatography, immunoprecipitation, and two-dimensional oligopeptide mapping methods. The env gene specifies a glycosylated polypeptide with a molecular weight of 160,000 (gp160) that is processed to gp120 and smaller gene products. The gag gene specifies two polypeptides of 70,000 and 55,000 molecular weight (p70 and p55), both of which contain p24, the major structural protein of the mature virion. The techniques in this study can be used to define the extent of variability of the env gene product among different virus isolates and may identify the nature and patterns of the humoral immune response that lead to an immunologically protected state.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Towbin, H., Staehelin, T., & Gordon, J. (1979) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.76.9.4350 · Cited by 53,385
Barré-Sinoussi, F., Chermann, J. C., Rey, F., Nugeyre, M. T., Chamaret, S., Gruest, J., Dauguet, C., Axler-Blin, C., Vézinet-Brun, F., Rouzioux, C., et al. (1983) · Science · doi:10.1126/science.6189183 · Cited by 7,038
Gallo, R. C., Salahuddin, S. Z., Popovic, M., Shearer, G. M., Kaplan, M., Haynes, B. F., Palker, T. J., Redfield, R., Oleske, J., Safai, B., et al. (1984) · Science · doi:10.1126/science.6200936 · Cited by 3,641
Self-citationPopovic, M., Sarngadharan, M. G., Read, E., & Gallo, R. C. (1984) · Science · doi:10.1126/science.6200935 · Cited by 3,535
Self-citationSarngadharan, M. G., Popovic, M., Bruch, L., Schüpbach, J., & Gallo, R. C. (1984) · Science · doi:10.1126/science.6324345 · Cited by 1,148
Self-citationShaw, G. M., Hahn, B. H., Arya, S. K., Groopman, J. E., Gallo, R. C., & Wong-Staal, F. (1984) · Science · doi:10.1126/science.6095449 · Cited by 633
Self-citationSchüpbach, J., Popovic, M., Gilden, R. V., Gonda, M. A., Sarngadharan, M. G., & Gallo, R. C. (1984) · Science · doi:10.1126/science.6200937 · Cited by 610
Self-citationSequence Homology and Morphologic Similarity of HTLV-III and Visna Virus, a Pathogenic Lentivirus
Gonda, M. A., Wong-Staal, F., Gallo, R. C., Clements, J. E., Narayan, O., & Gilden, R. V. (1985) · Science · doi:10.1126/science.2981428 · Cited by 405
Self-citationEssex, M., McLane, M. F., Lee, T. H., Falk, L., Howe, C. W. S., Mullins, J. I., Cabradilla, C., & Francis, D. P. (1983) · Science · doi:10.1126/science.6342136 · Cited by 352
Yoshinaka, Y., Katoh, I., Copeland, T. D., & Oroszlan, S. (1985) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.82.6.1618 · Cited by 335
Self-citation
Cited by
Leonard, C. K., Spellman, M. W., Riddle, L., Harris, R. J., Thomas, J. N., & Gregory, T. J. (1990) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)86956-3 · Cited by 985
Functional Regions of the Envelope Glycoprotein of Human Immunodeficiency Virus Type 1
Kowalski, M., Potz, J., Basiripour, L., Dorfman, T., Goh, W. C., Terwilliger, E., Dayton, A., Rosen, C., Haseltine, W., & Sodroski, J. (1987) · Science · doi:10.1126/science.3629244 · Cited by 848
Showing your ID: intrinsic disorder as an ID for recognition, regulation and cell signaling
Uversky, V. N., Oldfield, C. J., & Dunker, A. K. (2005) · Journal of Molecular Recognition · doi:10.1002/jmr.747 · Cited by 847
A second post-transcriptional trans-activator gene required for HTLV-III replication
Sodroski, J., Goh, W. C., Rosen, C., Dayton, A., Terwilliger, E., & Haseltine, W. (1986) · Nature · doi:10.1038/321412a0 · Cited by 631
The trans-activator gene of the human T cell lymphotropic virus type III is required for replication
Dayton, A. (1986) · Cell · doi:10.1016/0092-8674(86)90017-6 · Cited by 621
Rusche, J. R., Javaherian, K., McDanal, C., Petro, J., Lynn, D. L., Grimaila, R., Langlois, A., Gallo, R. C., Arthur, L. O., & Fischinger, P. J. (1988) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.85.9.3198 · Cited by 620
Self-citationPrincipal neutralizing domain of the human immunodeficiency virus type 1 envelope protein.
Javaherian, K., Langlois, A. J., McDanal, C., Ross, K. L., Eckler, L. I., Jellis, C. L., Profy, A. T., Rusche, J. R., Bolognesi, D. P., & Putney, S. D. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.17.6768 · Cited by 618
Thali, M., Moore, J. P., Furman, C., Charles, M., Ho, D. D., Robinson, J., & Sodroski, J. (1993) · Journal of Virology · doi:10.1128/jvi.67.7.3978-3988.1993 · Cited by 616
Endoproteolytic cleavage of gp160 is required for the activation of human immunodeficiency virus
McCune, J. M., Rabin, L. B., Feinberg, M. B., Lieberman, M., Kosek, J. C., Reyes, G. R., & Weissman, I. L. (1988) · Cell · doi:10.1016/0092-8674(88)90487-4 · Cited by 610
Dissociation of gp120 from HIV-1 Virions Induced by Soluble CD4
Moore, J. P., McKeating, J. A., Weiss, R. A., & Sattentau, Q. J. (1990) · Science · doi:10.1126/science.2251501 · Cited by 576
Characterization of Highly Immunogenic p66/p51 as the Reverse Transcriptase of HTLV-III/LAV
di Marzo Veronese, F., Copeland, T. D., DeVico, A. L., Rahman, R., Oroszlan, S., Gallo, R. C., & Sarngadharan, M. G. (1986) · Science · doi:10.1126/science.2418504 · Cited by 545
Self-citationGoedert, J. J., Kessler, C. M., Aledort, L. M., Biggar, R. J., Andes, W. A., White, G. C., Drummond, J. E., Vaidya, K., Mann, D. L., Eyster, M. E., et al. (1989) · New England Journal of Medicine · doi:10.1056/nejm198910263211701 · Cited by 524
HIV‐1 neutralizing antibodies: understanding nature's pathways
Mascola, J. R., & Haynes, B. F. (2013) · Immunological Reviews · doi:10.1111/imr.12075 · Cited by 475
Characterization of gp41 as the Transmembrane Protein Coded by the HTLV-III/LAV Envelope Gene
Veronese, F. D., DeVico, A. L., Copeland, T. D., Oroszlan, S., Gallo, R. C., & Sarngadharan, M. G. (1985) · Science · doi:10.1126/science.2994223 · Cited by 437
Self-citationWyatt, R., Moore, J., Accola, M., Desjardin, E., Robinson, J., & Sodroski, J. (1995) · Journal of Virology · doi:10.1128/jvi.69.9.5723-5733.1995 · Cited by 417
Olshevsky, U., Helseth, E., Furman, C., Li, J., Haseltine, W., & Sodroski, J. (1990) · Journal of Virology · doi:10.1128/jvi.64.12.5701-5707.1990 · Cited by 405
Structures of HIV-1 gp120 Envelope Glycoproteins from Laboratory-Adapted and Primary Isolates
Kwong, P. D., Wyatt, R., Majeed, S., Robinson, J., Sweet, R. W., Sodroski, J., & Hendrickson, W. A. (2000) · Structure · doi:10.1016/s0969-2126(00)00547-5 · Cited by 390
Siliciano, R. F., Lawton, T., Knall, C., Karr, R. W., Berman, P., Gregory, T., & Reinherz, E. L. (1988) · Cell · doi:10.1016/0092-8674(88)90078-5 · Cited by 369
Whitcomb, J. M., Huang, W., Fransen, S., Limoli, K., Toma, J., Wrin, T., Chappey, C., Kiss, L. D. B., Paxinos, E. E., & Petropoulos, C. J. (2007) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00853-06 · Cited by 356
Alterations in T4 (CD4) Protein and mRNA Synthesis in Cells Infected with HIV
Hoxie, J. A., Alpers, J. D., Rackowski, J. L., Huebner, K., Haggarty, B. S., Cedarbaum, A. J., & Reed, J. C. (1986) · Science · doi:10.1126/science.3095925 · Cited by 340
Primary Human T-Lymphotropic Virus Type III Infection
HO, D. D., SARNGADHARAN, M. G., RESNICK, L., DIMARZOVERONESE, F., ROTA, T. R., & HIRSCH, M. S. (1985) · Annals of Internal Medicine · doi:10.7326/0003-4819-103-6-880 · Cited by 334
HTLV-III/LAV-Neutralizing Antibodies to an E. coli -Produced Fragment of the Virus Envelope
Putney, S. D., Matthews, T. J., Robey, W. G., Lynn, D. L., Robert-Guroff, M., Mueller, W. T., Langlois, A. J., Ghrayeb, J., Petteway, S. R., Weinhold, K. J., et al. (1986) · Science · doi:10.1126/science.2431482 · Cited by 332
Self-citationLightfoote, M. M., Coligan, J. E., Folks, T. M., Fauci, A. S., Martin, M. A., & Venkatesan, S. (1986) · Journal of Virology · doi:10.1128/jvi.60.2.771-775.1986 · Cited by 310
Oligomeric structure of gp41, the transmembrane protein of human immunodeficiency virus type 1
Pinter, A., Honnen, W. J., Tilley, S. A., Bona, C., Zaghouani, H., Gorny, M. K., & Zolla-Pazner, S. (1989) · Journal of Virology · doi:10.1128/jvi.63.6.2674-2679.1989 · Cited by 291
Chertova, E., Bess, Crise, B. J., Sowder, R. C., Schaden, T. M., Hilburn, J. M., Hoxie, J. A., Benveniste, R. E., Lifson, J. D., Henderson, L. E., et al. (2002) · Journal of Virology · doi:10.1128/jvi.76.11.5315-5325.2002 · Cited by 290
Self-citationFarzan, M., Choe, H., Martin, K., Marcon, L., Hofmann, W., Karlsson, G., Sun, Y., Barrett, P., Marchand, N., Sullivan, N., et al. (1997) · The Journal of Experimental Medicine · doi:10.1084/jem.186.3.405 · Cited by 289
Yang, X., Lee, J., Mahony, E. M., Kwong, P. D., Wyatt, R., & Sodroski, J. (2002) · Journal of Virology · doi:10.1128/jvi.76.9.4634-4642.2002 · Cited by 277
NARA, P. L., HATCH, W. C., DUNLOP, N. M., ROBEY, W. G., ARTHUR, L. O., GONDA, M. A., & FISCHINGER, P. J. (1987) · AIDS Research and Human Retroviruses · doi:10.1089/aid.1987.3.283 · Cited by 272
Self-citationVeillette, M., Désormeaux, A., Medjahed, H., Gharsallah, N.-E., Coutu, M., Baalwa, J., Guan, Y., Lewis, G., Ferrari, G., Hahn, B. H., et al. (2014) · Journal of Virology · doi:10.1128/jvi.03230-13 · Cited by 265
Morris, L., Binley, J. M., Clas, B. A., Bonhoeffer, S., Astill, T. P., Kost, R., Hurley, A., Cao, Y., Markowitz, M., Ho, D. D., et al. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.188.2.233 · Cited by 254
Metadata
- Authors
- Robey, W. G., Safai, B., Oroszlan, S., Arthur, L. O., Gonda, M. A., Gallo, R. C., & Fischinger, P. J.
- Venue
- Science
- Published
- 1985-05-03
- Volume
- 228
- Issue
- 4699
- Pages
- 593-595
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- OpenAlex
- W2008493977
- Cited by
- 349
- References
- 15
- FWCI
- 6.44
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.